<DOC>
	<DOCNO>NCT02195687</DOCNO>
	<brief_summary>This study evaluate safety efficacy BOTOX® ( botulinum toxin Type A ) compare placebo patient moderate severe crow 's foot line ( lateral canthal line ) .</brief_summary>
	<brief_title>BOTOX® Treatment Crow 's Feet Lines China</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Moderate severe Crow 's Feet Lines . Current previous treatment botulinum toxin serotype condition within last year Diagnosis myasthenia gravis , EatonLambert syndrome , amyotrophic lateral sclerosis Facial laser light treatment , microdermabrasion chemical peel within 3 month Radio frequency laser treatment , phototherapy , blepharoplasty , browlift related procedure , permanent makeup , oral retinoid therapy treatment nonpermanent soft tissue filler within 1 year Any mediumdepth deep facial peel within 5 year Periorbital surgery , facelift , mid facial periorbital treatment permanent soft tissue filler , synthetic implant autologous fat transplant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>